Company profile
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc.

Pipeline5 assets

  • RopidoxuridineIPdR / Radiation Sensitizer / Small Molecule / Oncology
    GlioblastomaPhase 2ActiveUnited StatesSarcomasPhase 1/Phase 2ActiveUnited States
  • SP-2-225SP-2-225 / HDAC6 / Small Molecule / Oncology
    Breast Cancer / Solid TumorsPreclinicalActiveUnited States
  • SP-1-303SP-1-303 / Class I HDAC / Small Molecule / Oncology
    ER+ Breast CancerPreclinicalActiveUnited States
  • SP-1-161SP-1-161 / HDAC / Small Molecule / Oncology
    Solid TumorsDiscoveryActiveUnited States
  • PSMA-B ligandPSMA-B / PSMA / Radiopharmaceutical / Oncology
    Metastatic Prostate CancerPreclinicalActiveUnited States

Latest news7 items

All news

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Gaithersburg, Maryland–(Newsfile Corp. – March 26, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), today announced a major advancement to its molecule.ai platform, significantly expanding its capabilities in therapeutic discovery and positioning the Company at the forefront of AI-driven drug development....

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Gaithersburg, Maryland–(Newsfile Corp. – March 6, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), the owner of Molecule.ai, an artificial intelligence (“AI”) driven platform for molecular discovery and early-stage drug development, today announced that it has entered into a securities purchase agreement...

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs – and Why Molecule.ai’s Drug Discovery Platform Matters More Than Ever

Gaithersburg, Maryland–(Newsfile Corp. – January 13, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), applauds the state of Utah which has become the first state in the United States to allow artificial intelligence systems to authorize prescription refills without direct physician involvement — a regulatory...

Shuttle Pharmaceuticals Holdings, Inc. • Endpoint Arena